Atypical CF and CF related diseases

https://doi.org/10.1016/j.prrv.2006.04.219Get rights and content

Summary

The clinical characteristics of atypical CF are: symptoms that may start in infancy but the disease become clinically significant only after 10 years of age, survival into adulthood, chronic sinopulmonary disease, pancreatic sufficiency, and sweat chloride <60 meq/L. Other patients may present with single organ involvement such as CBAVD, biliary cirrhosis and portal hypertension, chronic or recurrent pancreatitis, giant nasal polyposis or hypochloremic alkalosis. It is recommended to refer such patients for CFTR genotyping, however, absence of known common mutation does not rule out CFTR associated disease, since mutations causing atypical CF are rare and whole genome scan is required for their identification. Nasal PD measurements may be helpful to establish the diagnosis of these patients; however, measurements might be also atypical. Several explanations have been suggested to explain the atypical CF disease.

References (10)

There are more references available in the full text version of this article.

Cited by (36)

  • ECFS standards of care on CFTR-related disorders: Updated diagnostic criteria

    2022, Journal of Cystic Fibrosis
    Citation Excerpt :

    In fact, the correct identification and adequate clinical monitoring of patients with CFTR-RD is often limited by clinical practice insufficiently informed by clear guidelines. It is indeed difficult to delineate exactly where CF stops and CFTR-RD begins and not infrequently these patients receive inconsistent messages [6–18]. The European Cystic Fibrosis Society (ECFS) and its Diagnostic Network Working Group assembled a panel of experts to produce standards of care for the diagnosis and management of CFTR-RD. This document is the first of a sequence of four papers dedicated to this topic.

  • Contribution of M470V variant to cystic fibrosis: First study in CF and normal Tunisian population

    2015, Pathologie Biologie
    Citation Excerpt :

    Currently, over than 1900 sequence variations have been described within the CFTR gene, along with geographic and ethnic variations in their distribution and frequency. These variations confer somewhat variable phenotypes from classic CF to atypical CF with less severe pulmonary lesions, pancreatic sufficiency, and normal or borderline sweat chloride concentration [2]. Additional effects of genetic factors (genetic markers and modifier genes) and/or environmental factors may cause clinical heterogeneity of CF. The most common polymorphism M470V in European populations was the subject of several studies in CF, CF-related diseases and healthy cohorts revealing its role as a predisposing genetic factor.

  • Genetic risk factors for pancreatic disorders

    2013, Gastroenterology
    Citation Excerpt :

    The more common variants are classified clinically as severe or mild, based on their effect on pancreatic function. An accepted molecular classification strategy organizes the variants by their effects on CFTR function, with class I–III variants causing severe dysfunction and class IV–V causing reduced or altered function.61,62 Class IV–V variants have mild to variable effects on the pancreas and other organs, often leaving sufficient function for basic physiological needs but not enough to handle stress.

  • Mild cystic fibrosis in patients with the rare P5L CFTR mutation

    2012, Journal of Cystic Fibrosis
    Citation Excerpt :

    In recent years it has been acknowledged that there is a wide clinical spectrum of disease associated with the CFTR mutations. About 10% of the patients present a mild form of CF often involving a single organ dysfunction, in many cases with mild respiratory symptoms, pancreatic sufficiency and normal or borderline sweat test [3–5]. Because of the unusual presentation, the diagnosis of these “non classic” cystic fibrosis can be difficult to make.

View all citing articles on Scopus
View full text